Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis

US9951388B2 · kind B2 · utility

Assignees

• Ventana Medical Systems, Inc. · US
• Cornell University · IT

Inventors

• Francesca Demichelis · New York, US
• Karl Garsha · Sahuarita, US
• Phillip C. Miller · Tucson, US
• Ray B. Nagle · Tucson, US
• Michael Otter · Tucson, US
• Gary Pestano · Lafayette, US
• Mark A. Rubin · New York, US

Key dates

• Filing date: May 7, 2012
• Grant date: Apr 24, 2018
• Expiry date: May 11, 2034

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02E60/10
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.